Driehaus Capital Management’s MacroGenics MGNX Stock Holding History

Driehaus Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-121,029	Closed	-$2.27M	–	604
2016 Q1	$2.27M	Sell	121,029 -196,614	-62%	-$3.74M	0.07%	264
2015 Q4	$9.84M	Buy	317,643 +62,428	+24%	+$1.9M	0.33%	70
2015 Q3	$5.47M	Sell	255,215 -73,665	-22%	-$2.31M	0.2%	124
2015 Q2	$12.5M	Sell	328,880 -38,697	-11%	-$1.27M	0.43%	53
2015 Q1	$11.5M	Buy	367,577 +175,538	+91%	+$5.95M	0.4%	55
2014 Q4	$6.74M	Buy	192,039 +109,509	+133%	+$2.73M	0.27%	95
2014 Q3	$1.73M	Buy	82,530 +22,735	+38%	+$470K	0.07%	353
2014 Q2	$1.3M	Sell	59,795 -1,631	-3%	-$34.3K	0.04%	408
2014 Q1	$1.71M	Buy	+61,426	New	+$2.17M	0.05%	352

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Driehaus Capital Management's MGNX Position: Q2 2016 in Review

Driehaus Capital Management sold out of MacroGenics (MGNX) in Q2 2016, closing a stake of 121,029 shares — an estimated $2.27M sold.

Driehaus Capital Management first reported a position in MGNX in Q1 2014 and held it in 9 quarters. The position peaked at $12.5M in Q2 2015. 125 funds tracked by Wall St. Rank hold MGNX as of Q2 2016.

Driehaus Capital Management reported no remaining MacroGenics position as of Q2 2016 after selling out during the quarter.
Driehaus Capital Management sold 121,029 MacroGenics shares in Q2 2016, an estimated $2.27M.
Driehaus Capital Management first reported a position in MacroGenics in Q1 2014 and held it in 9 quarters.
Driehaus Capital Management's MacroGenics position peaked at $12.5M in Q2 2015.
125 funds tracked by Wall St. Rank held MacroGenics as of Q2 2016.

Based on Driehaus Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.